Uveitis: Clinical Trials

2 trials for Uveitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 2

Follow Uveitis: new trials by email Literature Review of Uveitis trials Research Report on Uveitis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II
Valganciclovir, Ganciclovir (GCV), Placebo - Cytomegalovirus (CMV), Anterior Uveitis
Phase 2Not yet recruitingUniversity of California, San Francisco1172026-11-012026-08-11
Corticotropin for Behçet's Disease: A Multicenter Randomized Controlled TrialAcronym.
Repository Corticotropin Injection (ACTH), Study-matched inactive placebo injection, also called control injection - Behçet's Syndrome, Behçet's Syndrome (BS)
Phase 2Not yet recruitingPeking University People's Hospital602026-09-012026-09-22

Narrower conditions

Behcet Syndrome (1)  ·  Cytomegalovirus Infections (1)  ·  Uveitis, Anterior (1)

Broader conditions

Eye Diseases (2)  ·  Panuveitis (2)  ·  Uveal Diseases (2)  ·  Cardiovascular Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  DNA Virus Infections (1)  ·  Genetic Diseases, Inborn (1)  ·  Hereditary Autoinflammatory Diseases (1)  ·  Herpesviridae Infections (1)  ·  Infections (1)  ·  Mouth Diseases (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Genetic (1)  ·  Skin Diseases, Vascular (1)

Interventions

Adrenocorticotropic Hormone (1)  ·  Ganciclovir (1)  ·  Valganciclovir (1)

Sponsors

Peking University People's Hospital (1)  ·  University of California, San Francisco (1)

Countries

China (1)  ·  Taiwan (1)  ·  Thailand (1)  ·  United States (1)

Top investigators

John A Gonzales, MD (1)

Results publications

PMID 1970380

NIH funding

UG1EY036344 (1)